Akzo Nobel Insiders Added €4.02m Of Stock To Their Holdings

Quite a few insiders have dramatically grown their holdings in Akzo Nobel N.V. (AMS:AKZA) over the past 12 months. An insider's optimism about the company's prospects is a positive sign.

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

The Last 12 Months Of Insider Transactions At Akzo Nobel

Over the last year, we can see that the biggest insider purchase was by CEO & Chairman of the Management Board Gregoire Poux-Guillaume for €2.8m worth of shares, at about €60.40 per share. That means that an insider was happy to buy shares at around the current price of €61.92. Of course they may have changed their mind. But this suggests they are optimistic. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. Happily, the Akzo Nobel insiders decided to buy shares at close to current prices. We note that Gregoire Poux-Guillaume was both the biggest buyer and the biggest seller.

Happily, we note that in the last year insiders paid €4.0m for 66.49k shares. But they sold 20.77k shares for €1.3m. In the last twelve months there was more buying than selling by Akzo Nobel insiders. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

See our latest analysis for Akzo Nobel

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

Insider Ownership Of Akzo Nobel

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 0.08% of Akzo Nobel shares, worth about €8.2m, according to our data. Whilst better than nothing, we're not overly impressed by these holdings.

So What Do The Akzo Nobel Insider Transactions Indicate?

It doesn't really mean much that no insider has traded Akzo Nobel shares in the last quarter. On a brighter note, the transactions over the last year are encouraging. While we have no worries about the insider transactions, we'd be more comfortable if they owned more Akzo Nobel stock. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To that end, you should learn about the 3 warning signs we've spotted with Akzo Nobel (including 1 which shouldn't be ignored).

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.